“…One possible reason for the divergent Find ings in the literature may be species-or disease-spe cific differences in the responsiveness of the cells. For example, guinea pig eosinophils respond to leuko triene B4 (LTB4), both in vivo and in vitro [2,3], while platelet-activating factor (PAF) induces only little in vitro, but good in vivo migration of eosinophils in that species [2,4], the latter being due to secondary, platelet-related events [4], With human eosinophils, on the other hand, PAF has been reported to be a po tent chemoattractant both in vivo and in vitro [5,6]. In the present investigation, we have tried to confirm these data with cells from a variety of patients with dermatological diseases with low and high eosinophil counts.…”